Galectin Therapeutics Reports First Quarter 2015 Financial Results, Provides Business Update Including Phase 2 NASH Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. DCOY
5. SPY
6. MSFT
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to Galectin Therapeutics Reports First Quarter 2015 Financial Results, Provides Business Update Including Phase 2 NASH Program
GALECTIN (NASDAQ: GALT) Delayed: 4.14 +0.18 (4.55%)
Previous Close $3.96    52 Week High $3.05 
Open $4.05    52 Week Low $0.49 
Day High $4.24    P/E N/A 
Day Low $4.05    EPS $-1.32 
Volume 258,069